Product Information

OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1635 per EA under NDC 67877045390. Its NADAC has been published 72 times since Jul 9, 2025.

FDA first approved this application on Jul 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
$0.1635per EA

Strength

12.5; 20 mg/1; mg/1

NDC

67877045390

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207037

FDA Approved

7/11/2024

TE Code

AB

On Market Since

5/1/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 72 times since Jul 9, 2025, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1635 per EA
All-time high$0.1999 (Jul 16, 2025)
All-time low$0.1635 (Nov 18, 2026)
52-week high$0.1842
52-week low$0.1635
Median price$0.1741
Average price$0.1754
Largest weekly change-10.0% (Sep 17, 2025)
Weeks tracked72
Tracking sinceJul 9, 2025

Price History

1W

-0.3%

1M

-0.9%

3M

-9.4%

6M

-6.6%

1Y

-2.9%

3Y

N/A

5Y

N/A

All

-18.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.1635 per EA (NDC 67877045390), effective Nov 18, 2026.

How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 18.2%. It has been tracked across 72 weekly CMS publications since Jul 9, 2025.

What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Jul 9, 2025, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1635 (Nov 18, 2026) to a high of $0.1999 (Jul 16, 2025), with a median of $0.1741 per EA.

Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 67877045390) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.